Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$47.86 - $75.05 $23.5 Million - $36.8 Million
-490,000 Reduced 96.08%
20,000 $1.08 Million
Q1 2024

May 03, 2024

BUY
$63.75 - $108.06 $32.5 Million - $55.1 Million
510,000 New
510,000 $35.8 Million
Q3 2020

Nov 03, 2020

SELL
$20.58 - $28.96 $419,831 - $590,784
-20,400 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$11.15 - $24.64 $227,460 - $502,656
20,400 New
20,400 $174,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.77B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.